• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

并作为溃疡性结肠炎患者复发的预后标志物。

and as prognostic markers for relapse in ulcerative colitis patients.

机构信息

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.

ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.

出版信息

Front Cell Infect Microbiol. 2024 Jul 4;14:1367998. doi: 10.3389/fcimb.2024.1367998. eCollection 2024.

DOI:10.3389/fcimb.2024.1367998
PMID:39027140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11254828/
Abstract

INTRODUCTION

Ulcerative colitis is an inflammatory disorder characterized by chronic inflammation in the gastrointestinal tract, mainly in the colon and rectum. Although the precise etiology of ulcerative colitis remains unclear, recent research has underscored the significant role of the microbiome in its development and progression.

METHODS

The aim of this study was to establish a relationship between the levels of specific gut bacterial species and disease relapse in ulcerative colitis. For this study, we recruited 105 ulcerative colitis patients in remission and collected clinical data, blood, and stool samples. and levels were quantified in the stool samples of ulcerative colitis patients. Binary logistic regression was applied to collected data to predict disease remission.

RESULTS

The median time in remission in this cohort was four years. A predictive model incorporating demographic information, clinical data, and the levels of and was developed to understand remission patterns.

DISCUSSION

Our findings revealed a negative correlation between the levels of these two microorganisms and the duration of remission. These findings highlight the importance of the gut microbiota in ulcerative colitis for disease prognosis and for personalized treatments based on microbiome interventions.

摘要

简介

溃疡性结肠炎是一种炎症性疾病,其特征为胃肠道(主要是结肠和直肠)慢性炎症。尽管溃疡性结肠炎的确切病因仍不清楚,但最近的研究强调了微生物组在其发展和进展中的重要作用。

方法

本研究旨在建立特定肠道细菌种类的水平与溃疡性结肠炎复发之间的关系。为此,我们招募了 105 名处于缓解期的溃疡性结肠炎患者,并收集了临床数据、血液和粪便样本。在溃疡性结肠炎患者的粪便样本中定量检测 和 的水平。采用二元逻辑回归对收集的数据进行分析,以预测疾病缓解。

结果

本队列的中位缓解时间为四年。我们建立了一个包含人口统计学信息、临床数据和 和 水平的预测模型,以了解缓解模式。

讨论

我们的发现揭示了这两种微生物的水平与缓解时间之间存在负相关关系。这些发现强调了肠道微生物组在溃疡性结肠炎疾病预后中的重要性,以及基于微生物组干预的个体化治疗的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/11254828/593360715bb6/fcimb-14-1367998-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/11254828/8dc07e9cabe2/fcimb-14-1367998-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/11254828/593360715bb6/fcimb-14-1367998-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/11254828/8dc07e9cabe2/fcimb-14-1367998-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/11254828/593360715bb6/fcimb-14-1367998-g002.jpg

相似文献

1
and as prognostic markers for relapse in ulcerative colitis patients.并作为溃疡性结肠炎患者复发的预后标志物。
Front Cell Infect Microbiol. 2024 Jul 4;14:1367998. doi: 10.3389/fcimb.2024.1367998. eCollection 2024.
2
and synergistically protect from colitis by promoting ILC3 in the gut.并通过促进肠道中的 ILC3 协同保护免受结肠炎。
mBio. 2024 Apr 10;15(4):e0007824. doi: 10.1128/mbio.00078-24. Epub 2024 Mar 12.
3
Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.饮用豆浆对溃疡性结肠炎患者肠道微生物群、炎症标志物和疾病严重程度的影响:一项随机临床试验研究方案。
Trials. 2020 Jun 23;21(1):565. doi: 10.1186/s13063-020-04523-8.
4
Strain-Specific Anti-inflammatory Properties of Two Strains on Chronic Colitis in Mice.两种菌株对小鼠慢性结肠炎的菌株特异性抗炎特性。
Front Cell Infect Microbiol. 2019 Jul 5;9:239. doi: 10.3389/fcimb.2019.00239. eCollection 2019.
5
Novel Gut Microbiota Modulator, Which Markedly Increases Akkermansia muciniphila Occupancy, Ameliorates Experimental Colitis in Rats.新型肠道微生物群调节剂,显著增加阿克曼氏菌定植,改善大鼠实验性结肠炎。
Dig Dis Sci. 2022 Jul;67(7):2899-2911. doi: 10.1007/s10620-021-07131-x. Epub 2021 Jul 14.
6
Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation.阿克曼氏菌(Akkermansia muciniphila)通过激活 NLRP3 缓解葡聚糖硫酸钠(DSS)诱导的急性结肠炎。
Microbiol Spectr. 2021 Oct 31;9(2):e0073021. doi: 10.1128/Spectrum.00730-21. Epub 2021 Oct 6.
7
The effects of live and pasteurized on DSS-induced ulcerative colitis, gut microbiota, and metabolomics in mice.双歧杆菌和乳酸杆菌对 DSS 诱导的溃疡性结肠炎、肠道微生物群和代谢组学的影响。
Food Funct. 2023 May 22;14(10):4632-4646. doi: 10.1039/d2fo03493j.
8
Exerts Strain-Specific Effects on DSS-Induced Ulcerative Colitis in Mice.对 DSS 诱导的小鼠溃疡性结肠炎具有应变特异性作用。
Front Cell Infect Microbiol. 2021 Aug 4;11:698914. doi: 10.3389/fcimb.2021.698914. eCollection 2021.
9
Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota.溃疡性结肠炎缓解期患者的肠道微生物组成与健康人群接近。
Inflamm Bowel Dis. 2023 Sep 1;29(9):1362-1369. doi: 10.1093/ibd/izad058.
10
The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis.阿克曼氏菌属黏液厚壁菌的丰度及其与健康和溃疡性结肠炎中结肠硫酸盐黏蛋白的关系。
Sci Rep. 2019 Oct 30;9(1):15683. doi: 10.1038/s41598-019-51878-3.

引用本文的文献

1
Parabacteroides as a promising target for disease intervention: current stage and pending issues.副拟杆菌作为疾病干预的一个有前景的靶点:现状与待解决问题
NPJ Biofilms Microbiomes. 2025 Jul 19;11(1):137. doi: 10.1038/s41522-025-00772-0.
2
Parabacteroides johnsonii inhibits the onset and progression of colorectal cancer by modulating the gut microbiota.约翰逊副拟杆菌通过调节肠道微生物群来抑制结直肠癌的发生和发展。
J Transl Med. 2025 Jul 2;23(1):734. doi: 10.1186/s12967-025-06675-0.

本文引用的文献

1
and synergistically protect from colitis by promoting ILC3 in the gut.并通过促进肠道中的 ILC3 协同保护免受结肠炎。
mBio. 2024 Apr 10;15(4):e0007824. doi: 10.1128/mbio.00078-24. Epub 2024 Mar 12.
2
Alterations in metabolome and microbiome: new clues on cathelicidin-related antimicrobial peptide alleviates acute ulcerative colitis.代谢组和微生物组的改变:与cathelicidin相关的抗菌肽缓解急性溃疡性结肠炎的新线索。
Front Microbiol. 2024 Feb 6;15:1306068. doi: 10.3389/fmicb.2024.1306068. eCollection 2024.
3
Linking microbial genes to plasma and stool metabolites uncovers host-microbial interactions underlying ulcerative colitis disease course.
将微生物基因与血浆和粪便代谢物联系起来,揭示了溃疡性结肠炎疾病进程中宿主-微生物相互作用的机制。
Cell Host Microbe. 2024 Feb 14;32(2):209-226.e7. doi: 10.1016/j.chom.2023.12.013. Epub 2024 Jan 11.
4
The impact of gut microbiome enterotypes on ulcerative colitis: identifying key bacterial species and revealing species co-occurrence networks using machine learning.肠道微生物组 enterotypes 对溃疡性结肠炎的影响:使用机器学习识别关键细菌物种并揭示物种共存网络。
Gut Microbes. 2024 Jan-Dec;16(1):2292254. doi: 10.1080/19490976.2023.2292254. Epub 2023 Dec 20.
5
Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota.溃疡性结肠炎缓解期患者的肠道微生物组成与健康人群接近。
Inflamm Bowel Dis. 2023 Sep 1;29(9):1362-1369. doi: 10.1093/ibd/izad058.
6
Serological Biomarker-Based Machine Learning Models for Predicting the Relapse of Ulcerative Colitis.基于血清生物标志物的机器学习模型预测溃疡性结肠炎复发
J Inflamm Res. 2023 Aug 21;16:3531-3545. doi: 10.2147/JIR.S423086. eCollection 2023.
7
A Critical Review on Akkermansia muciniphila: Functional Mechanisms, Technological Challenges, and Safety Issues.阿克曼氏菌属黏液亚种的批判性综述:功能机制、技术挑战和安全问题。
Probiotics Antimicrob Proteins. 2024 Aug;16(4):1376-1398. doi: 10.1007/s12602-023-10118-x. Epub 2023 Jul 11.
8
Mirikizumab: First Approval.米利珠单抗:首个获批
Drugs. 2023 Jul;83(11):1045-1052. doi: 10.1007/s40265-023-01909-1.
9
A Critical Perspective on the Supplementation of : Benefits and Harms.对……补充的批判性视角:益处与危害
Life (Basel). 2023 May 24;13(6):1247. doi: 10.3390/life13061247.
10
Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019.204 个国家和地区 1990 年至 2019 年炎症性肠病的全球、区域和国家负担:基于 2019 年全球疾病负担研究的系统分析。
BMJ Open. 2023 Mar 28;13(3):e065186. doi: 10.1136/bmjopen-2022-065186.